Coronavirus cases in India: The recovery rate is 96.12%.
New Delhi:
India added 19,079 coronavirus infections in the past 24 hours, putting its total number at 1.03 million cases, data from the Health Ministry showed. The number of new infections is 5% lower than on Friday. In this period, India reported 224 deaths related to the virus, bringing the total number of deaths to 1.49,218.
Meanwhile, a trial will take place in every state today to verify the best way to vaccinate people against COVID-19 and plug the gaps in logistics and training. This unit will also test the operational feasibility of using the CoWIN application in a field environment. CoWIN, short for Covid Vaccine Intelligence Network, is a digital platform to implement and expand the vaccination campaign.
The massive exercise comes a day after a government-appointed panel of experts recommended approval of the Oxford COVID-19 vaccine, made by the Serum Institute of India, to the regulator Drugs Control Authority of India.
Here are the LIVE updates on coronavirus cases:
“A certificate of emergency use must take into account that there are certain unknowns about the vaccine and ensure that there is a communication unit simultaneously”: Anant Bhan, researcher pic.twitter.com/ocMVzbR4Of
– NDTV (@ndtv) January 2, 2021
In order to prepare medical personnel and infrastructure, the COVID-19 vaccine trial will continue regularly in Assam until vaccination is carried out, a senior official said on Saturday.
Speaking with PTI, the director of the mission of the National Health Mission (NHM), Lakshmanan S, said that the Department of Health does not want to leave a stone unturned to discover any loophole in the system before administering the vaccine to the people of the state.
“Today we are going to conduct the test at Gauhati Hospital and Medical College, Sonapur Civil Hospital and Khanapara State Dispensary. This will be an ongoing process and we will have tests until the vaccine arrives,” he added. .
A test for COVID-19 vaccination is being carried out at three centers in West Bengal with at least 75 health workers participating in the program on Saturday, an official said.
The exercise began at 9 am at the Urban Primary Health Centers in Duttabad and Madhyagram and at the Amdanga Rural Hospital in North 24 Parganas district, he said.
“At least 75 people are participating in the program at three centers. They have been asked to register their names for the mock vaccination. Their health status will be observed for at least 30 minutes after the end of the exercise,” the official said. .
The test was part of the nationwide exercise to test the preparedness of the authorities before launching the actual vaccination program.
All passengers coming from the UK between January 8 and January 30 will undergo self-pay COVID-19 tests upon arrival, the Health Ministry said in a standard operating procedure (SOP) issued on Saturday.
Additionally, each passenger arriving from the UK would have to bring their negative COVID-19 report from a test conducted 72 hours before travel, the SOP noted.
India had suspended all flights to and from the UK from December 23 to December 31 to check for the spread of the most contagious and mutated variant of the coronavirus found there. Subsequently, the suspension was extended until January 7.
Only 30 flights per week will operate between India and the United Kingdom when services resume from January 8 and this agreement will continue until January 23, Aviation Minister Hardeep Singh Puri said on Friday.
Pfizer Inc and its partner BioNTech plan to give volunteers who received a placebo in their COVID-19 vaccine trial an option to receive a first dose of the vaccine before March 1, 2021, while they remain in the study.
The trial vaccine transition option allows all participants 16 years of age or older the option to find out if they received the placebo, “and participants who learn they received the placebo have the option of receiving the investigational vaccine while they stay in the studio. ” the companies said on their website for trial participants.
The US Food and Drug Administration and a panel of its outside advisers have raised concerns about Pfizer’s “unmasking” plan, saying it could make it difficult to collect the safety and efficacy data needed to gain full approval. of the vaccine by the FDA.
Only in | India registers 19,079 new cases, 5% less than yesterday; Rs 1.03 crore total cases, 1.49 lakh deaths so far
The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be submitted for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts.
The Serum Institute of India (SII) is manufacturing the Covishield vaccine developed by the University of Oxford and leading drugmaker AstraZeneca, while Bharat Biotech has partnered with the Indian Council for Medical Research (ICMR) for its Covaxin.
Pfizer had sought more time to present its data to the expert panel.
The center is looking to begin administering vaccines starting this month, once the DCGI authorizes the vaccine for the last time.
An immunization test is scheduled today in every state.
Approximately two million doses of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca will be delivered every week in mid-January in the UK, The Times reported.
AstraZeneca expects to supply two million doses of the vaccine in total by next week, the newspaper reported, citing an anonymous member of the Oxford-AstraZeneca team. “The plan is to develop it fairly quickly; by the third week of January we should reach 2 million a week,” the report adds.
The company was not immediately available to respond to a request for comment from Reuters.
The report comes after Britain approved the Oxford-AstraZeneca COVID-19 vaccine on Wednesday, in hopes that swift action will help stem a record surge in infections driven by a highly contagious form of the virus.
A trial will take place in every state today to verify the best way to vaccinate people against COVID-19 and to fill the gaps in logistics and training.
This unit will also test the operational feasibility of using the CoWIN application in a field environment. CoWIN, short for Covid Vaccine Intelligence Network, is a digital platform to implement and expand the vaccination campaign.
The massive exercise comes a day after a government-appointed panel of experts recommended approval of the Oxford COVID-19 vaccine, made by the Serum Institute of India, to the regulator Drugs Control Authority of India.
Pfizer Inc and its partner BioNTech plan to give volunteers who received a placebo in their COVID-19 vaccine trial an option to receive a first dose of the vaccine before March 1, 2021, while they remain in the study.
The trial vaccine transition option allows all participants 16 years of age or older the option to find out if they received the placebo, “and participants who learn they received the placebo have the option of receiving the investigational vaccine while they stay in the studio. ” the companies said on their website for trial participants.
The US Food and Drug Administration and a panel of its outside advisers have raised concerns about Pfizer’s “unmasking” plan, saying it could make it difficult to collect the safety and efficacy data needed to gain full approval. of the vaccine by the FDA.
Efforts are under way to track 75 people who have traveled to Karnataka from the UK and authorities hope to locate them soon, state Health Minister K Sudhakar said on Friday.
The number of returnees from the UK who tested positive for the new coronavirus strain prevalent in the European nation stood at seven and genomic sequencing results were awaited for another 31, he told reporters here.
“We have yet to track 75 people who traveled from the UK … some foreign nationals are also there who might not have local contact numbers, their details have been collected from the immigration department,” Sudhakar said.
The French government announced on Friday that it will advance its nightly curfew by two hours in 15 regions to help fight the coronavirus, as infections remain high.
The 15 of the 101 departments in France affected by Saturday’s change to a curfew that begins at 6:00 pm instead of 8:00 pm, include the department of Les Alpes-Maritimes, where the city is located. Mediterranean of Nice.
The other areas are concentrated in the east of the country.
Paris, for now, has gotten rid of the additional restriction.
“The virus continues to spread in France … but with a disparity between regions,” said government spokesman Gabriel Attal when announcing the measure.
“If the situation deteriorates further in certain areas, we will make the necessary decisions,” he told broadcaster TF1.
Britain reactivated emergency hospitals built at the start of the pandemic and closed primary schools in London on Friday to counter the rapid spread of a much more infectious variant of the coronavirus.
With more than 50,000 new COVID-19 cases daily over the past four days, the health service said it was preparing for an anticipated flood of patients and needed more beds.
The announcement comes just days after the Royal London Hospital told staff in an email that it was now in “disaster medicine mode” and could not provide high-level critical care.
.
